Impact of Fibroblast Growth Factor-23 on Peripheral Arterial Disease in Type 2 Diabetes Mellitus: A Comparative Cross-Sectional Pilot Study


Hatipoglu E., Ozgur N., Niyazoglu M., Dikici A. S., Ekmekci O. B., Yalin S., ...More

TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, vol.19, no.4, pp.119-123, 2015 (ESCI, Scopus)

Abstract

Purpose: To evaluate whether fibroblast growth factor-23 (FGF-23) has a common role in the pathogenesis of peripheral arterial disease (PAD) and chronic kidney disease (CKD) in type-2 diabetes mellitus (DM).